Standout Papers

Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With <s... 2018 2026 2020 2023 258
  1. Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial (2018)
    Jonathan Strosberg, Edward M. Wolin et al. Journal of Clinical Oncology

Immediate Impact

1 from Science/Nature 60 standout
Sub-graph 1 of 20

Citing Papers

EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Metabolic reprogramming in the tumor microenvironment of liver cancer
2024 Standout
2 intermediate papers

Works of Beth Chasen being referenced

A Prospective Phase II Study of Safety and Efficacy of Sorafenib Followed by 90Y Glass Microspheres for Patients with Advanced or Metastatic Hepatocellular Carcinoma
2021
Health-Related Quality of Life in Patients With Progressive Midgut Neuroendocrine Tumors Treated With 177Lu-Dotatate in the Phase III NETTER-1 Trial
2018 Standout

Author Peers

Author Last Decade Papers Cites
Beth Chasen 249 353 332 19 539
S Garancini 172 287 222 20 557
Maribel Lopera Sierra 342 497 440 24 616
Thomas Rink 173 252 213 22 523
Osama Al‐Saif 110 142 194 29 466
Sven‐Petter Haugvik 205 355 409 20 512
Simon Meller 200 111 79 14 486
Johanna M. Zuetenhorst 309 381 302 15 460
Torjan Haslerud 338 448 432 21 633
Katherine Yao 123 179 321 16 587
Judy L. Smith 119 197 235 23 526

All Works

Loading papers...

Rankless by CCL
2026